BioCentury | Sep 9, 2013
Company News

Galantos, Neurodyn deal

...Neurodyn acquired lead Alzheimer's candidate Memogain from Galantos for an undisclosed sum. Neurodyn said Memogain completed...
...growth factor progranulin ( PGRN ; PCDGF ) and is in preclinical testing for PD. Galantos Pharma GmbH...
BioCentury | May 10, 2010
Financial News

Galantos completes venture financing

Galantos Pharma GmbH , Mainz, Germany Business: Neurology Date completed: 4/30/10 Type: Venture financing Raised: €4.4 million ($5.8 million) Investors: VRP Rheinland-Pfalz; KfW; FIB Fonds for Innovation and Employment; WFT; High-Tech Gruenderfonds; Federal Ministry of Education...
BioCentury | Mar 31, 2008
Clinical News

Progalantamine: Phase I start

...Next year, Galantos will begin a Phase I trial. Last week’s selection of the candidate molecule...
...of a series B round, bringing the total raised in the round to E2.8 million. Galantos Pharma GmbH...
Items per page:
1 - 3 of 3
BioCentury | Sep 9, 2013
Company News

Galantos, Neurodyn deal

...Neurodyn acquired lead Alzheimer's candidate Memogain from Galantos for an undisclosed sum. Neurodyn said Memogain completed...
...growth factor progranulin ( PGRN ; PCDGF ) and is in preclinical testing for PD. Galantos Pharma GmbH...
BioCentury | May 10, 2010
Financial News

Galantos completes venture financing

Galantos Pharma GmbH , Mainz, Germany Business: Neurology Date completed: 4/30/10 Type: Venture financing Raised: €4.4 million ($5.8 million) Investors: VRP Rheinland-Pfalz; KfW; FIB Fonds for Innovation and Employment; WFT; High-Tech Gruenderfonds; Federal Ministry of Education...
BioCentury | Mar 31, 2008
Clinical News

Progalantamine: Phase I start

...Next year, Galantos will begin a Phase I trial. Last week’s selection of the candidate molecule...
...of a series B round, bringing the total raised in the round to E2.8 million. Galantos Pharma GmbH...
Items per page:
1 - 3 of 3